Bisoprolol may decrease the bronchodilatory activities of Procaterol. The risk or severity of adverse effects can be increased when Triamterene is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Indacaterol. Azelastine may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Promazine. The metabolism of Bisoprolol can be decreased when combined with Imipramine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Perindopril. Tenoxicam may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Ritonavir. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Acetylcholine. The metabolism of Bisoprolol can be decreased when combined with Imatinib. Mycophenolate mofetil may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the bronchoconstrictory activities of Methacholine. Bisoprolol may increase the orthostatic hypotensive activities of Trimazosin. Phenylbutazone may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Darifenacin. The metabolism of Bisoprolol can be decreased when combined with Cyclosporine. Bisoprolol may decrease the bronchodilatory activities of Orciprenaline. The metabolism of Bisoprolol can be increased when combined with Rifabutin. Zomepirac may decrease the antihypertensive activities of Bisoprolol. Valdecoxib may decrease the antihypertensive activities of Bisoprolol. Bromocriptine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol. Felbinac may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carbachol. Bisoprolol may increase the hypotensive activities of Terlipressin. BL-1020 may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Moexipril. Barbital may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypoglycemic activities of Tolbutamide. Bisoprolol may increase the hypotensive activities of Platelet Activating Factor. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Riociguat. Loxoprofen may decrease the antihypertensive activities of Bisoprolol. Methanesulfonyl Fluoride may increase the bradycardic activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Cimetidine. Lornoxicam may decrease the antihypertensive activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Bosentan. Evening primrose oil may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Vinpocetine. Udenafil may increase the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Methadone. Suprofen may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Chlorpromazine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Metipranolol. The risk or severity of adverse effects can be increased when Sodium Nitrite is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Diphenhydramine. Bisoprolol may increase the hypotensive activities of Tibolone. Bisoprolol may increase the hypoglycemic activities of Gliclazide. Sulfasalazine may decrease the antihypertensive activities of Bisoprolol. Thiethylperazine may increase the hypotensive activities of Bisoprolol. The serum concentration of Mepivacaine can be increased when it is combined with Bisoprolol. Bisoprolol may increase the hypoglycemic activities of Insulin Human. Tolfenamic Acid may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Sevoflurane is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Cevimeline. Isoxicam may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Thalidomide is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Isoetarine. The risk or severity of adverse effects can be increased when Diltiazem is combined with Bisoprolol. Bisoprolol may decrease the bronchodilatory activities of Dyphylline. Etoricoxib may decrease the antihypertensive activities of Bisoprolol. Moricizine may increase the hypotensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Primaquine. Iloprost may increase the hypotensive activities of Bisoprolol. The serum concentration of Bisoprolol can be increased when it is combined with Milnacipran. The metabolism of Bisoprolol can be decreased when combined with Tranylcypromine. Bisoprolol may increase the bradycardic activities of Midodrine. The serum concentration of Bisoprolol can be increased when it is combined with Levomilnacipran. Reserpine may increase the hypotensive activities of Bisoprolol. Curcumin may decrease the antihypertensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Methyldopa. Bisoprolol may increase the bradycardic activities of Fingolimod. Bisoprolol may decrease the bronchodilatory activities of Phenylpropanolamine. The risk or severity of adverse effects can be increased when Tolcapone is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Fosamprenavir. Metamizole may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the bradycardic activities of Calfactant. Apomorphine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Mesalazine may decrease the antihypertensive activities of Bisoprolol. Digoxin may increase the bradycardic activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Pilocarpine. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Cilazapril. Vardenafil may increase the antihypertensive activities of Bisoprolol. Bretylium may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the vasoconstricting activities of Cabergoline. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Indapamide. PTC299 may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Ambrisentan. Carprofen may decrease the antihypertensive activities of Bisoprolol. Huperzine A may increase the bradycardic activities of Bisoprolol. Bisoprolol may increase the orthostatic hypotensive activities of Tamsulosin. Bisoprolol may increase the atrioventricular blocking (AV block) activities of Lacosamide. Benzphetamine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Lobeline. The serum concentration of Bisoprolol can be increased when it is combined with Fusidic Acid. Pyridostigmine may increase the bradycardic activities of Bisoprolol. Pergolide may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Serrapeptase may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Phentolamine. The metabolism of Bisoprolol can be decreased when combined with Lorcaserin. The risk or severity of adverse effects can be increased when Amiloride is combined with Bisoprolol. Clonidine may increase the atrioventricular blocking (AV block) activities of Bisoprolol. Demecarium may increase the bradycardic activities of Bisoprolol. The serum concentration of Bisoprolol can be decreased when it is combined with Vemurafenib. The metabolism of Bisoprolol can be increased when combined with Rifapentine. The metabolism of Bisoprolol can be decreased when combined with Midostaurin. Diflunisal may decrease the antihypertensive activities of Bisoprolol. Salsalate may decrease the antihypertensive activities of Bisoprolol. Toloxatone may increase the hypotensive activities of Bisoprolol. Alfuzosin may increase the hypotensive activities of Bisoprolol. Isocarboxazid may increase the hypotensive activities of Bisoprolol. The risk or severity of adverse effects can be increased when Propofol is combined with Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Venlafaxine. The serum concentration of Bisoprolol can be increased when it is combined with Palbociclib. Guanadrel may increase the hypotensive activities of Bisoprolol. Methylphenidate may decrease the antihypertensive activities of Bisoprolol. The metabolism of Bisoprolol can be decreased when combined with Mirabegron. The risk or severity of adverse effects can be increased when Bisoprolol is combined with Felodipine. Ketorolac may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Candoxatril. Bisoprolol may increase the hypotensive activities of Amifostine. Dronedarone may increase the bradycardic activities of Bisoprolol. Methohexital may increase the hypotensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Nilvadipine. The serum concentration of Bisoprolol can be increased when it is combined with Etoperidone. The metabolism of Bisoprolol can be decreased when combined with Ketoconazole. Zaltoprofen may decrease the antihypertensive activities of Bisoprolol. Bisoprolol may increase the hypotensive activities of Deserpidine. The risk or severity of adverse effects can be increased when Carteolol is combined with Bisoprolol. Iproniazid may increase the hypotensive activities of Bisoprolol.